Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin82.9%-2.1pp85%+0.5pp84.5%+0.5pp84%-0.3pp84.3%+1.7pp
Operating margin-17.2%-10.9pp-6.3%+1.6pp-7.9%-0.8pp-7.1%+0.9pp-8%+9.0pp
Net margin-17.6%-11.2pp-6.4%+1.7pp-8.1%-1.1pp-7%+1.0pp-8%+9.1pp
Returns
Return on equity-29.4%-17.5pp-11.9%+1.2pp-13.1%-2.3pp-10.8%+0.9pp-11.7%+13.0pp
Return on invested capital-42.2%-25.6pp-16.6%+6.2pp-22.8%-3.8pp-19%+0.7pp-19.7%+20.3pp
Efficiency
Asset turnover0.6×0.0×0.6×0.0×0.6×0.0×0.6×0.0×0.5×+0.1×
Liquidity
Current ratio-0.1×-0.2×1.2×-0.1×1.3×+0.1×1.2×+0.1×
Leverage
Debt-to-equity0.2×0.0×0.2×0.0×0.2×0.0×0.2×0.0×0.2×-0.3×
Per Share
Book value per share$1.45-13.6%$1.67-4.1%$1.75-6.7%$1.87-0.4%$1.88+15.5%
Valuation
Market capitalization$97.09M+142%$59.53M+27.5%$46.68M-5.5%$49.37M-16.4%$59.09M+77.5%
Price / sales2.3×+1.4×1.3×+0.2×1.1×0.0×1.2×-0.3×1.4×+0.6×
Price / book4.5×+3.1×2.4×+0.6×1.8×0.0×1.8×-0.3×2.1×+0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Cumberland Pharmaceuticals's profit margins?
Cumberland Pharmaceuticals (CPIX) runs a 82.9% gross margin and a -17.2% operating margin, with a -17.6% net margin.
Where do Cumberland Pharmaceuticals's ratios come from?
Every ratio is computed from Cumberland Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.